ProFibrix

Sealonix

This company develops bioabsorbable hemostatic sealant patches to control surgical bleeding for healthcare providers performing abdominopelvic and orthopaedic procedures.

Abyrx

The company develops and manufactures resorbable hemostatic bone putties and biomaterial devices for surgeons performing orthopaedic, spinal, and cardiothoracic procedures.

Clotprotect Therapeutics

This company develops small molecule anti-fibrinolytic drugs for patients suffering from acute haemorrhage and severe bleeding.

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

VarmX

This biotech company develops recombinant blood clotting factors to treat patients with severe bleeding or requiring urgent surgery while taking oral anticoagulants.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

Confluent Surgical

The company develops and manufactures synthetic polymer-based sealants and adhesion barriers for surgical clinicians to prevent fluid leaks and post-operative complications during procedures.

ProFactor Pharma

This company develops recombinant Factor VIII to treat haemophilia A in patients who currently lack access to affordable medication.